These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3929304)

  • 1. Effect of metergoline on human anxiety.
    Graeff FG; Zuardi AW; Giglio JS; Lima Filho EC; Karniol IG
    Psychopharmacology (Berl); 1985; 86(3):334-8. PubMed ID: 3929304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of CO2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline.
    Ben-Zion IZ; Meiri G; Greenberg BD; Murphy DL; Benjamin J
    Am J Psychiatry; 1999 Oct; 156(10):1635-7. PubMed ID: 10518177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple simulated public speaking test for evaluating anxiolytic drugs.
    Guimarães FS; Kohem CL; Gus G; Fillmann HS; de-Vecino MC; de-Paoli CL; Ribeiro AM; Teixeira CC; Wannmacher L
    Braz J Med Biol Res; 1989; 22(9):1083-9. PubMed ID: 2699823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE; Sprugel KH; Hadley KB; Roth RA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature of 5-HT1-like receptors mediating depressor responses in vagosympathectomized rats; close resemblance to the cloned 5-ht7 receptor.
    De Vries P; Villalón CM; Heiligers JP; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):90-9. PubMed ID: 9228195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker.
    Bourgoin S; Artaud F; Bockaert J; Héry F; Glowinski J; Hamon M
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):313-21. PubMed ID: 662027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects of nefazodone in two human models of anxiety.
    Silva M; Hetem LA; Guimarães FS; Graeff FG
    Psychopharmacology (Berl); 2001 Aug; 156(4):454-60. PubMed ID: 11498723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between two models of experimental anxiety in healthy volunteers and panic disorder patients.
    Graeff FG; Silva M; Del Ben CM; Zuardi AW; Hetem LA; Guimarães FS
    Neurosci Biobehav Rev; 2001 Dec; 25(7-8):753-9. PubMed ID: 11801299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline.
    Stolz JF; Marsden CA
    J Physiol (Paris); 1981; 77(2-3):385-8. PubMed ID: 6974778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-fenfluramine reduces anxiety induced by simulated public speaking.
    Hetem LA; de-Souza CJ; Guimarães FS; Zuardi AW; Graeff FG
    Braz J Med Biol Res; 1993 Sep; 26(9):971-4. PubMed ID: 7507765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of metergoline to affect the circadian periodicity of plasma cortisol levels in healthy man.
    Degli Uberti E; Trasforini G; Margutti A; Rotola C; Lo Vecchio G
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):367-73. PubMed ID: 7236416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C; Murphy DL; Zohar J; Hill JL; Grover G; Insel TR
    Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal from chronic treatment with metergoline, dl-propranolol and amitriptyline enhances serotonin receptor mediated behaviour in the rat.
    Stolz JF; Marsden CA
    Eur J Pharmacol; 1982 Apr; 79(1-2):17-22. PubMed ID: 7200899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chlorimipramine and maprotiline on experimental anxiety in humans.
    Guimarães FS; Zuardi AW; Graeff FG
    J Psychopharmacol; 1987 Jan; 1(3):184-92. PubMed ID: 22158980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ipsapirone and cannabidiol on human experimental anxiety.
    Zuardi AW; Cosme RA; Graeff FG; Guimarães FS
    J Psychopharmacol; 1993 Jan; 7(1 Suppl):82-8. PubMed ID: 22290374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa.
    Pontiroli AE; Viberti GC; Tognetti A; Pozza G
    Horm Metab Res; 1976 Mar; 8(2):106-8. PubMed ID: 1261961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT1-like receptor mediating the increase in canine external carotid blood flow: close resemblance to the 5-HT1D subtype.
    Villalón CM; Terrón JA
    Br J Pharmacol; 1994 Sep; 113(1):13-20. PubMed ID: 7812603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.